Login / Signup

Differences in E-Cadherin and Syndecan-1 Expression in Different Types of Ameloblastomas.

Ramón G Carreón-BurciagaRogelio González GonzálezNelly Molina-FrecheroSandra López-VerdínVanesa Pereira-PradoRonell Eduardo Bologna-Molina
Published in: Analytical cellular pathology (Amsterdam) (2018)
Ameloblastomas are a group of benign, locally aggressive, recurrent tumors characterized by their slow and infiltrative growth. E-Cadherin and syndecan-1 are cell adhesion molecules related to the behavior of various tumors, including ameloblastomas. Ninety-nine ameloblastoma samples were studied; the expression of E-cadherin and syndecan-1 were evaluated by immunohistochemistry. E-Cadherin and epithelial syndecan-1 were more highly expressed in intraluminal/luminal unicystic ameloblastoma than in mural unicystic ameloblastoma and solid/multicystic ameloblastoma, whereas the stromal expression of syndecan-1 was higher in mural unicystic ameloblastoma and solid/multicystic ameloblastoma. Synchronicity was observed between E-cadherin and epithelial syndecan-1; the expression was correlated with intensity in all cases. There was a strong association between expression and tumor size and recurrence. The evaluation of the expression of E-cadherin and syndecan-1 are important for determining the potential aggressiveness of ameloblastoma variants. Future studies are required to understand how the expression of these markers is related to tumor aggressiveness.
Keyphrases
  • poor prognosis
  • binding protein
  • long non coding rna
  • bone marrow
  • cell adhesion
  • risk assessment
  • dna methylation
  • genome wide